Care Ratings Assigns CARE A- Rating to Dharmaj Crop Guard's ₹249.00 Crore Bank Facilities
Care Ratings Limited assigned CARE A- with Stable outlook and CARE A2+ ratings to Dharmaj Crop Guard Limited's bank facilities totaling ₹249.00 crore on February 18, 2026. The ratings are supported by extensive promoter experience, diversified product portfolio, and growing operations with total operating income of ₹951.66 crore in FY25. However, ratings are constrained by moderate profitability margins of 7.94% PBILDT in FY25, working capital intensive operations, and exposure to competitive industry dynamics and regulatory risks.

*this image is generated using AI for illustrative purposes only.
Dharmaj Crop Guard Limited has received fresh credit ratings from Care Ratings Limited, with the rating agency assigning investment-grade ratings to the agrochemical manufacturer's bank facilities worth ₹249.00 crore on February 18, 2026.
Rating Assignment Details
Care Ratings assigned the following ratings to Dharmaj Crop Guard's banking facilities:
| Facilities/Instruments | Amount (₹ Crore) | Rating | Rating Action |
|---|---|---|---|
| Long-term bank facilities | 69.93 | CARE A-; Stable | Assigned |
| Long-term/Short-term bank facilities | 122.87 | CARE A-; Stable/CARE A2+ | Assigned |
| Short-term bank facilities | 57.20 (Enhanced from 40.00) | CARE A2+ | Assigned |
The stable outlook reflects Care Ratings' expectation that the company will continue benefiting from its promoters' extensive experience in the agrochemical industry while maintaining a comfortable financial risk profile.
Key Rating Strengths
Promoter Experience and Market Position
The rating agency highlighted the extensive experience of promoters Ramesh Talavia and Jaman Talavia, who possess over three decades of experience in the agrochemical industry. This expertise has enabled the company to build brand presence and establish an extensive distribution network across domestic and international markets.
Diversified Operations and Growing Scale
Dharmaj Crop Guard operates with a well-diversified revenue mix across three segments. In FY25, branded formulations contributed approximately 20% of total operating income, institutional formulations 59%, and technicals 21%. The company's total operating income grew at a healthy compound annual growth rate of approximately 37% over the last five years, reaching ₹951.66 crore in FY25.
The company's manufacturing capabilities include two facilities with a combined capacity of 25,500 MTPA for formulations and 8,000 MTPA for technicals and intermediates. In H1FY26, the company reported continued sales momentum with total operating income of ₹714.65 crore, representing 26% year-on-year growth.
Financial Performance Metrics
| Brief Financials (₹ crore) | March 31, 2024 | March 31, 2025 | H1FY26 |
|---|---|---|---|
| Total operating income | 654.58 | 951.66 | 714.65 |
| PBILDT | 63.42 | 75.54 | 82.53 |
| Profit after tax | 44.38 | 34.84 | 49.92 |
| Overall gearing (x) | 0.31 | 0.32 | 0.38 |
| Interest coverage (x) | 18.46 | 5.86 | 10.83 |
The company maintains a comfortable capital structure with tangible net worth of ₹392.36 crore as of FY25 end and moderate reliance on external debt, leading to overall gearing of 0.32x as of March 31, 2025.
Rating Constraints
Profitability and Working Capital Challenges
Despite the positive factors, Care Ratings noted several constraints. The company's profitability remained moderate with PBILDT margins in the range of 8-12% over the last five years. PBILDT margin moderated by 175 basis points year-on-year to 7.94% in FY25 due to commercialization of the technical plant, while PAT margin declined to 3.66% in FY25 from 6.78% in FY24.
The company's operations are working capital intensive, with overall inventory days remaining stable at 50-52 days while debtor days expanded from approximately 55 days to 70 days over three years ended FY25. The operating cycle stood at 64 days as of March 31, 2025.
Industry and Regulatory Risks
The ratings also factor in the company's presence in the highly competitive agrochemical industry, where intense competition from organized and unorganized players exerts pricing pressure. Additionally, the company's profitability remains susceptible to regulatory and climatic conditions, as demand for crop protection products depends on monsoons and pest attack incidence.
Rating Sensitivities
Care Ratings outlined specific factors that could lead to rating actions. Positive factors include growth in scale of operations with total operating income exceeding ₹1,400 crore and PBILDT margin above 12% on a sustained basis. Negative factors include significant decline in total operating income and PBILDT margin below 8%, total debt to PBILDT above 2x, or total outside liabilities to tangible net worth above 0.80x on a sustained basis.
The company's liquidity profile remains adequate, with expected gross cash accruals of over ₹80 crore in FY26 against low term debt repayment obligations of approximately ₹12 crore. Average utilization for cash credit facilities stood at approximately 42% for the 12 months ended November 2025.
Historical Stock Returns for Dharmaj Crop Guard
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.16% | -6.17% | -0.12% | -29.09% | +24.94% | -11.20% |

































